Füsun Mayda Domaç
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Füsun Mayda Domaç has a total of 171 co-authors. Here are the top co-authors by number of shared publications:
- Rahşan Karacı
Department of Neurology, University of Health Sciences, Erenköy Psychiatry and Neurological Diseases Training and Research Hospital, İstanbul, Türkiye
6 shared publications - Esra Aydin Sunbul
Department of Psychiatry, University of Health Sciences Erenköy Mental Health and Neurological Diseases Training and Research Hospital, Istanbul, Turkey
5 shared publications - Hüseyin Güleç
Department of Psychiatry, University of Health Sciences Erenköy Mental Health and Neurological Diseases Training and Research Hospital, Istanbul, Turkey
5 shared publications - Busranur Oguz Selcuk
University of Health Sciences, Department of Neurology, Erenkoy Mental and Nervous Diseases Training and Research Hospital, Istanbul, Türkiye
3 shared publications - Deniz Kirac
Faculty of Medicine, Department of Medical Biology, Yeditepe University, Istanbul, Turkey
3 shared publications - Gulay Kenangil
Parkinson's Disease and Movement Disorders Center (PARMER) Istanbul Medipol University Istanbul Türkiye
3 shared publications
Latest Publications
- 6 November 2026
- Published by Taylor & Francis
- p. 244-251
Advances in Diagnostic Discovery
Wearable technology (WT) has expanded considerably in recent years, enabling continuous, real-time collection of physiological and behavioral data in free-living conditions. Sensors embedded in smartwatches, wristbands, headbands, rings, and patches can measure heart rate, heart rate variability, oxygen saturation, skin conductance, body temperature, and physical activity. These data streams hold promise for understanding disease mechanisms, supporting early diagnosis, and enabling personalized management. Actigraphy, photoplethysmography-based devices, biofeedback wearables, neurostimulators, and electroencephalography-enabled devices have been evaluated in sleep medicine, headache disorders, and neurodegenerative diseases. In sleep medicine, wearables show utility in evaluating circadian rhythm disorders, insomnia, and sleep apnea risk. In headache research, biosensors combined with machine learning and event-related potentials are being explored to predict migraine attacks and quantify headache burden. In neurodegeneration, actigraphy-derived digital biomarkers may identify prodromal Parkinson’s disease, while gait and speech sensors assist in monitoring disease progression. This chapter reviews current advances in WT for diagnostic discovery across these interrelated conditions and discusses clinical opportunities, limitations, and future directions.
- 6 November 2026
- Published by Taylor & Francis
- p. 244-251
Advances in Diagnostic Discovery
Wearable technology (WT) has expanded considerably in recent years, enabling continuous, real-time collection of physiological and behavioral data in free-living conditions. Sensors embedded in smartwatches, wristbands, headbands, rings, and patches can measure heart rate, heart rate variability, oxygen saturation, skin conductance, body temperature, and physical activity. These data streams hold promise for understanding disease mechanisms, supporting early diagnosis, and enabling personalized management. Actigraphy, photoplethysmography-based devices, biofeedback wearables, neurostimulators, and electroencephalography-enabled devices have been evaluated in sleep medicine, headache disorders, and neurodegenerative diseases. In sleep medicine, wearables show utility in evaluating circadian rhythm disorders, insomnia, and sleep apnea risk. In headache research, biosensors combined with machine learning and event-related potentials are being explored to predict migraine attacks and quantify headache burden. In neurodegeneration, actigraphy-derived digital biomarkers may identify prodromal Parkinson’s disease, while gait and speech sensors assist in monitoring disease progression. This chapter reviews current advances in WT for diagnostic discovery across these interrelated conditions and discusses clinical opportunities, limitations, and future directions.
- 6 November 2026
- Published by Taylor & Francis
Headache and Sleep
This volume delves into the intricate relationship between headache disorders and sleep disturbances, particularly their intersection with neurodegenerative
- 6 November 2026
- Published by Taylor & Francis
Headache and Sleep
This volume delves into the intricate relationship between headache disorders and sleep disturbances, particularly their intersection with neurodegenerative
- Open Access
- 3 February 2026
- Published by Springer Nature in BMC Surgery
- Vol. 26 (1)
Effect of bariatric surgery on headache frequency, duration and severity
This retrospective cross-sectional study aimed to investigate the differences and influencing factors between the headache patients who achieved complete r
- 3 February 2026
- Published by Springer Nature in BMC Surgery
- Vol. 26 (1)
Open AccessEffect of bariatric surgery on headache frequency, duration and severity
This retrospective cross-sectional study aimed to investigate the differences and influencing factors between the headache patients who achieved complete r
- 3 January 2026
- Published by Springer Nature
- p. 127-134
Primary Headache Associated with Sexual Activity
- 3 January 2026
- Published by Springer Nature
- p. 127-134
Primary Headache Associated with Sexual Activity
- 1 January 2026
- Published by Ideggyogyaszati Szemle Journal in Ideggyogyaszati Szemle
- Vol. 79 (1-2) , 59-68
Relationship between headache types and severity with psychiatric comorbidity in adolescents
Background and purpose Headache is a prevalent health concern among children and adolescents, affecting approximately 54.4% of this population. It has a negative impact on functionality and is associated with psychiatric conditions. The aim of this study is to examine the prevalence and comorbidity of headache among adolescents seeking care at a child psychiatry outpatient clinic and to compare the psychiatric conditions of adolescents with and without headache by using specific assessment scales. Methods The study included a total of 306 patients (201 females, 105 males), comprising 108 adolescents with headache and 198 without headache, who were admitted to the Child&Adolescent Psychiatry Outpatient Clinic of a Mental and Nervous Diseas- es Training and Research Hospital. Patients presenting with complaints of headache were referred to the neurology department of the hospital for diagnosis and classification. The Schedule for Affective Disorders and Schizophrenia for School-Age Children - Present and Lifetime Version-Turkish Adaptation was administered to all participants. Additional self-report scales including the State-Trait Anxiety Inventory (STAI) Forms 1 and 2, the Children’s Depression Inventory (CDI), and the Young Internet Addiction Test - Short Form were given. Parents filled out the Conners’ Parent Rating Scale and the Turgay DSM-IV-Based Child and Adolescent Disruptive Behavior Disorders Screening and Rating Scale. Results Among participants, 35.3% (n=108) have reported headache, divided into two subgroups; 58 had migraine and 50 had tension-type headache. The prevalence of Generalized Anxiety Disorder as a comorbid diagnosis was found to be significantly higher in the migraine group compared to those without headache (p=0.009). Nevertheless, there was no difference between migraine and tension type headache groups in terms of comorbid psychiatric diagnoses (p>0,05). The participants in both headache groups exhibited significantly elevated scores on the CDI, STAI-1 and STAI-2 in comparison to those without headache (p < 0.001). A positive correlation was identified between headache severity and both depression and trait anxiety severity among participants with headache. When classified according to the course of headache, chronic migraine was associated with higher Turgay and Conners scores, while chronic tension-type headache showed significantly higher CDI, STAI-1, and STAI-2 scores compared to episodic forms (p = .003–.038). Conclusion Psychiatric comorbidities are common in adolescents with headache, necessitating a comprehensive assessment that considers both conditions. This approach is crucial, as it has the potential to significantly influence the diagnosis, severity, progression, and treatment of these comorbidities, thereby ensuring comprehensive care and superior outcomes for affected individuals.
- 1 January 2026
- Published by Ideggyogyaszati Szemle Journal in Ideggyogyaszati Szemle
- Vol. 79 (1-2) , 59-68
Relationship between headache types and severity with psychiatric comorbidity in adolescents
Background and purpose Headache is a prevalent health concern among children and adolescents, affecting approximately 54.4% of this population. It has a negative impact on functionality and is associated with psychiatric conditions. The aim of this study is to examine the prevalence and comorbidity of headache among adolescents seeking care at a child psychiatry outpatient clinic and to compare the psychiatric conditions of adolescents with and without headache by using specific assessment scales. Methods The study included a total of 306 patients (201 females, 105 males), comprising 108 adolescents with headache and 198 without headache, who were admitted to the Child&Adolescent Psychiatry Outpatient Clinic of a Mental and Nervous Diseas- es Training and Research Hospital. Patients presenting with complaints of headache were referred to the neurology department of the hospital for diagnosis and classification. The Schedule for Affective Disorders and Schizophrenia for School-Age Children - Present and Lifetime Version-Turkish Adaptation was administered to all participants. Additional self-report scales including the State-Trait Anxiety Inventory (STAI) Forms 1 and 2, the Children’s Depression Inventory (CDI), and the Young Internet Addiction Test - Short Form were given. Parents filled out the Conners’ Parent Rating Scale and the Turgay DSM-IV-Based Child and Adolescent Disruptive Behavior Disorders Screening and Rating Scale. Results Among participants, 35.3% (n=108) have reported headache, divided into two subgroups; 58 had migraine and 50 had tension-type headache. The prevalence of Generalized Anxiety Disorder as a comorbid diagnosis was found to be significantly higher in the migraine group compared to those without headache (p=0.009). Nevertheless, there was no difference between migraine and tension type headache groups in terms of comorbid psychiatric diagnoses (p>0,05). The participants in both headache groups exhibited significantly elevated scores on the CDI, STAI-1 and STAI-2 in comparison to those without headache (p < 0.001). A positive correlation was identified between headache severity and both depression and trait anxiety severity among participants with headache. When classified according to the course of headache, chronic migraine was associated with higher Turgay and Conners scores, while chronic tension-type headache showed significantly higher CDI, STAI-1, and STAI-2 scores compared to episodic forms (p = .003–.038). Conclusion Psychiatric comorbidities are common in adolescents with headache, necessitating a comprehensive assessment that considers both conditions. This approach is crucial, as it has the potential to significantly influence the diagnosis, severity, progression, and treatment of these comorbidities, thereby ensuring comprehensive care and superior outcomes for affected individuals.
- Open Access
- 17 November 2025
- Published by Springer Nature in Obesity Surgery
- Vol. 35 (12) , 5471-5479
Effects of Bariatric Surgery on Sleep Disorder Symptoms and Sleep Quality
Objectives Obesity is related with several sleep disorders and affects the quality of life. In this research it was aimed to evaluate the effects of bariatric surgery on sleep disorders and sleep quality. Methods The study was conducted on 454 patients who underwent bariatric surgery at the Departments of General Surgery of Üsküdar University, Hitit University, Ondokuz Mayis University, and sleep disorders were evaluated at University of Health Sciences Erenköy Mental and Nervous Diseases Training and Research Hospital, Department of Neurology. Sleep quality of the patients, reporting complaints about sleep. was assessed with the Pittsburgh sleep quality index (PSQI), risk of obstructive sleep apnea syndrome was questioned with the Berlin Sleep Questionnaire (BSQ), excessive daytime sleepiness was screened with the Epworth Sleepiness Scale (ESS). The Insomnia Severity Index (ISI) was used in patients who identified insomnia and the restless legs syndrome severity scale (RLSS) index was also evaluated in patients with the complaints of RLS before and after the bariatric surgery. Results Among 454 patients, 207 of them (45.6%) have informed complaints about sleep. After bariatric surgery, all scores indicating impaired sleep quality (BSQ category 1 and category 2, RLS index, ESS, PSQI, ISI) decreased significantly in patients (p = 0.000). BSQ- scale scores had the greatest decrease among other scales. Patients also reported fewer complaints of sweating, sexual dysfunction, gastroosephageal reflux, teeth clenching, dry mouth, morning headache, nocturia, and daytime sleepiness after the surgery (p < 0.05). The decrease in body mass index (BMI) was significantly correlated with BSQ-OSAS total (r=-0.143; p < 0.05), RLS (r=-0.410; p < 0.05) and PSQI sleep latency (r = 0.174; p < 0.05). However, the correlation between BMI reduction and ESS, PSQI and ISI scores was found statistically insignificant. (p > 0.05). Effect of BMI difference on BSQ-OSAS was statistically significant (OR=-0.041; p < 0.05). Effects of BMI difference (OR=-0.490; p < 0.05) and having thyroid comorbidity (OR=-24.752; p < 0.01) on RLS were also statistically significant. Conclusion Bariatric surgery has a positive and healing effect on sleep apnea and restless legs syndrome in favor of this group of patients.
- 17 November 2025
- Published by Springer Nature in Obesity Surgery
- Vol. 35 (12) , 5471-5479
Open AccessEffects of Bariatric Surgery on Sleep Disorder Symptoms and Sleep Quality
Objectives Obesity is related with several sleep disorders and affects the quality of life. In this research it was aimed to evaluate the effects of bariatric surgery on sleep disorders and sleep quality. Methods The study was conducted on 454 patients who underwent bariatric surgery at the Departments of General Surgery of Üsküdar University, Hitit University, Ondokuz Mayis University, and sleep disorders were evaluated at University of Health Sciences Erenköy Mental and Nervous Diseases Training and Research Hospital, Department of Neurology. Sleep quality of the patients, reporting complaints about sleep. was assessed with the Pittsburgh sleep quality index (PSQI), risk of obstructive sleep apnea syndrome was questioned with the Berlin Sleep Questionnaire (BSQ), excessive daytime sleepiness was screened with the Epworth Sleepiness Scale (ESS). The Insomnia Severity Index (ISI) was used in patients who identified insomnia and the restless legs syndrome severity scale (RLSS) index was also evaluated in patients with the complaints of RLS before and after the bariatric surgery. Results Among 454 patients, 207 of them (45.6%) have informed complaints about sleep. After bariatric surgery, all scores indicating impaired sleep quality (BSQ category 1 and category 2, RLS index, ESS, PSQI, ISI) decreased significantly in patients (p = 0.000). BSQ- scale scores had the greatest decrease among other scales. Patients also reported fewer complaints of sweating, sexual dysfunction, gastroosephageal reflux, teeth clenching, dry mouth, morning headache, nocturia, and daytime sleepiness after the surgery (p < 0.05). The decrease in body mass index (BMI) was significantly correlated with BSQ-OSAS total (r=-0.143; p < 0.05), RLS (r=-0.410; p < 0.05) and PSQI sleep latency (r = 0.174; p < 0.05). However, the correlation between BMI reduction and ESS, PSQI and ISI scores was found statistically insignificant. (p > 0.05). Effect of BMI difference on BSQ-OSAS was statistically significant (OR=-0.041; p < 0.05). Effects of BMI difference (OR=-0.490; p < 0.05) and having thyroid comorbidity (OR=-24.752; p < 0.01) on RLS were also statistically significant. Conclusion Bariatric surgery has a positive and healing effect on sleep apnea and restless legs syndrome in favor of this group of patients.
- 11 July 2025
- Published by Springer Nature in Molecular Biology Reports
- Vol. 52 (1) , 1-7
Association of HLA-DRA, HLA-DQA1, and IL-6 gene variations with susceptibility to multiple sclerosis
Background Multiple sclerosis (MS), which can lead to severe physical or cognitive disability and neurological deficits, is a chronic autoimmune disease affecting the central nervous system (CNS). The etiology and pathogenesis of MS remain unclear; nonetheless, it is asserted that its cause is complex, with genetic predisposition playing a significant role. In this study, our aim was to analyze the relationship between MS and HLA-DRA (rs3135388 and rs3135391), HLA-DQA1 (rs9272346) and IL-6 (rs1800795 and rs1900796) gene polymorphisms, which play an important role in inflammation and immune response. Methods The study included 100 healthy controls and 98 MS patients. Real-time polymerase chain reaction (RT-PCR) was used to analyze variations in rs3135388 and rs3135391 in the HLA-DRA gene, rs9272346 in the HLA-DQA1 gene, and rs1800795 and rs1900796 in the IL-6 gene following DNA isolation from peripheral blood. Statistical techniques were applied to assess the outcomes. Results The results showed a significant difference in IL-6 (rs1800796) G/C (p = 0.024) between the patient and control groups when genotypes and allele distributions were analyzed. HLA-DQA1 (rs9272346) and HLA-DRA (rs3135388 and rs3135391) variations did not substantially differ between the two groups. Similarly, no significant difference was found between the two groups in VitD, B12 and folic acid parameters, and there was no relationship between these parameters and genotypes. Conclusion There is evidence suggesting a significant association between IL-6 (rs1800796) polymorphisms and MS. IL-6 (rs1800796) GC genotype may be associated with disease susceptibility or risk. This should be taken into account in association and intervention studies on MS.
- 11 July 2025
- Published by Springer Nature in Molecular Biology Reports
- Vol. 52 (1) , 1-7
Association of HLA-DRA, HLA-DQA1, and IL-6 gene variations with susceptibility to multiple sclerosis
Background Multiple sclerosis (MS), which can lead to severe physical or cognitive disability and neurological deficits, is a chronic autoimmune disease affecting the central nervous system (CNS). The etiology and pathogenesis of MS remain unclear; nonetheless, it is asserted that its cause is complex, with genetic predisposition playing a significant role. In this study, our aim was to analyze the relationship between MS and HLA-DRA (rs3135388 and rs3135391), HLA-DQA1 (rs9272346) and IL-6 (rs1800795 and rs1900796) gene polymorphisms, which play an important role in inflammation and immune response. Methods The study included 100 healthy controls and 98 MS patients. Real-time polymerase chain reaction (RT-PCR) was used to analyze variations in rs3135388 and rs3135391 in the HLA-DRA gene, rs9272346 in the HLA-DQA1 gene, and rs1800795 and rs1900796 in the IL-6 gene following DNA isolation from peripheral blood. Statistical techniques were applied to assess the outcomes. Results The results showed a significant difference in IL-6 (rs1800796) G/C (p = 0.024) between the patient and control groups when genotypes and allele distributions were analyzed. HLA-DQA1 (rs9272346) and HLA-DRA (rs3135388 and rs3135391) variations did not substantially differ between the two groups. Similarly, no significant difference was found between the two groups in VitD, B12 and folic acid parameters, and there was no relationship between these parameters and genotypes. Conclusion There is evidence suggesting a significant association between IL-6 (rs1800796) polymorphisms and MS. IL-6 (rs1800796) GC genotype may be associated with disease susceptibility or risk. This should be taken into account in association and intervention studies on MS.
- Open Access
- 10 June 2025
- Published by Wiley in Brain and Behavior
- Vol. 15 (6) , e70611
Revisiting Late‐Onset Bipolar Disorder Associated With Pituitary Adenoma: A Cross‐Sectional, Multidisciplinary, Case‐Based Analysis
Objective: This study explores the diagnostic, treatment, and follow‐up approaches of neurologists, psychiatrists, and family physicians in managing late‐onset bipolar disorder (BD) in elderly patients, emphasizing the role of interdisciplinary collaboration.Methods: A cross‐sectional survey involved 300 specialists (100 from each discipline). The survey assessed diagnostic accuracy, treatment preferences, follow‐up adherence, and barriers to interdisciplinary collaboration. A pairwise z‐test with Bonferroni correction was applied for comparative analysis across specialties to evaluate differences in response proportions.Results: Neurologists demonstrated high proficiency in imaging and treatment initiation (91% correct imaging responses) but faced challenges in holistic management and follow‐up adherence (2%). Psychiatrists excelled in diagnosing organic causes of mood disorders (92%) and therapeutic decisions but struggled with non‐priority diagnostic tests (44%) and long‐term follow‐up strategies (14%). Family physicians showed strong skills in pharmacological management (96%) and follow‐up adherence (89%) but encountered barriers like stigma and referral timing for high‐risk cases. Common interdisciplinary challenges included diagnostic communication, treatment coordination, and follow‐up collaboration.Conclusion: Late‐onset BD management requires a multidisciplinary approach to address specialty‐specific gaps and foster effective interdisciplinary collaboration. Enhanced training, integrated care models, and shared guidelines are recommended to optimize outcomes for elderly patients with mood disorders. Future research should focus on developing standardized protocols and evaluating the long‐term impact of interdisciplinary interventions.
- 10 June 2025
- Published by Wiley in Brain and Behavior
- Vol. 15 (6) , e70611
Open AccessRevisiting Late‐Onset Bipolar Disorder Associated With Pituitary Adenoma: A Cross‐Sectional, Multidisciplinary, Case‐Based Analysis
Objective: This study explores the diagnostic, treatment, and follow‐up approaches of neurologists, psychiatrists, and family physicians in managing late‐onset bipolar disorder (BD) in elderly patients, emphasizing the role of interdisciplinary collaboration.Methods: A cross‐sectional survey involved 300 specialists (100 from each discipline). The survey assessed diagnostic accuracy, treatment preferences, follow‐up adherence, and barriers to interdisciplinary collaboration. A pairwise z‐test with Bonferroni correction was applied for comparative analysis across specialties to evaluate differences in response proportions.Results: Neurologists demonstrated high proficiency in imaging and treatment initiation (91% correct imaging responses) but faced challenges in holistic management and follow‐up adherence (2%). Psychiatrists excelled in diagnosing organic causes of mood disorders (92%) and therapeutic decisions but struggled with non‐priority diagnostic tests (44%) and long‐term follow‐up strategies (14%). Family physicians showed strong skills in pharmacological management (96%) and follow‐up adherence (89%) but encountered barriers like stigma and referral timing for high‐risk cases. Common interdisciplinary challenges included diagnostic communication, treatment coordination, and follow‐up collaboration.Conclusion: Late‐onset BD management requires a multidisciplinary approach to address specialty‐specific gaps and foster effective interdisciplinary collaboration. Enhanced training, integrated care models, and shared guidelines are recommended to optimize outcomes for elderly patients with mood disorders. Future research should focus on developing standardized protocols and evaluating the long‐term impact of interdisciplinary interventions.
- 12 March 2025
- Published by Springer Nature in Biochemical Genetics
- Vol. 64 (1) , 1161-1173
Effects of HLA-DRA, HLA-DQA1 and IL-6 Gene Variations to Glatiramer Acetate Resistance in Multiple Sclerosis Patients
Multiple sclerosis (MS) is among the most common autoimmune disorders and is characterized by inflammation and degeneration affecting the central nervous system. Glatiramer acetate (GA) is an immunomodulatory drug utilized for treating relapsing–remitting MS. However, a considerable number of patients do not exhibit an appropriate response to this drug. This condition is known as GA resistance. This study aimed to investigate the relationship between nucleotide variations in the HLA-DRA, HLA-DQA1 and IL-6 genes and GA resistance. Additionally, the relationship of environmental factors with MS was investigated. One hundred thirty-nine MS patients were enrolled in this study. Patients were divided into two groups: non-responders (n = 58) and responders (n = 81). After DNA was isolated from peripheral blood, the rs3135388 and rs3135391 variations in HLA-DRA, the rs9272346 variation in HLA-DQA1, and the rs1800795 and rs1900796 variations in IL-6 were analyzed by Real-Time Polymerase Chain Reaction (RT-PCR). At the end of the study, it was found that the number of females was approximately 3 times greater in responders and 4 times greater in non-responders than in males. When nucleotide variations and allele distributions were compared between the groups, no significant relationships were found. Similarly, no significant relationship was found between risk factors and nucleotide variations. However, in non-responders, the expanded disability status scale and lesion load were found to be significantly high. In conclusion, by increasing the number of patients, more meaningful results can be achieved in future studies. Elucidating the pharmacogenetic characteristics (the drug–gene relationship) of MS patients using GA could lead to the development of personalized treatment strategies.
- 12 March 2025
- Published by Springer Nature in Biochemical Genetics
- Vol. 64 (1) , 1161-1173
Effects of HLA-DRA, HLA-DQA1 and IL-6 Gene Variations to Glatiramer Acetate Resistance in Multiple Sclerosis Patients
Multiple sclerosis (MS) is among the most common autoimmune disorders and is characterized by inflammation and degeneration affecting the central nervous system. Glatiramer acetate (GA) is an immunomodulatory drug utilized for treating relapsing–remitting MS. However, a considerable number of patients do not exhibit an appropriate response to this drug. This condition is known as GA resistance. This study aimed to investigate the relationship between nucleotide variations in the HLA-DRA, HLA-DQA1 and IL-6 genes and GA resistance. Additionally, the relationship of environmental factors with MS was investigated. One hundred thirty-nine MS patients were enrolled in this study. Patients were divided into two groups: non-responders (n = 58) and responders (n = 81). After DNA was isolated from peripheral blood, the rs3135388 and rs3135391 variations in HLA-DRA, the rs9272346 variation in HLA-DQA1, and the rs1800795 and rs1900796 variations in IL-6 were analyzed by Real-Time Polymerase Chain Reaction (RT-PCR). At the end of the study, it was found that the number of females was approximately 3 times greater in responders and 4 times greater in non-responders than in males. When nucleotide variations and allele distributions were compared between the groups, no significant relationships were found. Similarly, no significant relationship was found between risk factors and nucleotide variations. However, in non-responders, the expanded disability status scale and lesion load were found to be significantly high. In conclusion, by increasing the number of patients, more meaningful results can be achieved in future studies. Elucidating the pharmacogenetic characteristics (the drug–gene relationship) of MS patients using GA could lead to the development of personalized treatment strategies.